{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:18:20Z","timestamp":1788164300307,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Women's Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.crwh.2026.e00831","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:45:58Z","timestamp":1781801158000},"page":"e00831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Obstetrical and medical outcomes following GLP-1 receptor agonist exposure in pregnancy: a case series"],"prefix":"10.1016","volume":"51","author":[{"given":"Karen","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Al-Amri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Werlang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crwh.2026.e00831_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70021","article-title":"Pregnancy outcomes after semaglutide exposure","volume":"136","author":"Kolding","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.crwh.2026.e00831_bb0010","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1111\/dom.16437","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists\u2019 use during pregnancy: safety data from regulatory clinical trials","volume":"27","author":"Parker","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.crwh.2026.e00831_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.crwh.2026.e00831_bb0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.crwh.2026.e00831_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjcard.2025.03.013","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes","volume":"246","author":"Hanif","year":"2025","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.crwh.2026.e00831_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","article-title":"Glucagon-like peptide-1 receptor agonist use in pregnancy: a review","volume":"232","author":"Drummond","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.crwh.2026.e00831_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.20951","article-title":"Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation","author":"Maya","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.crwh.2026.e00831_bb0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.crwh.2026.e00831_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2023.05.022","article-title":"Guideline no. 442: fetal growth restriction: screening, diagnosis, and management in singleton pregnancies","volume":"45","author":"Kingdom","year":"2023","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.crwh.2026.e00831_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jogc.2016.09.012","article-title":"Amniotic fluid: technical update on physiology and measurement","volume":"39","author":"Lim","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.crwh.2026.e00831_bb0055","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/j.jcjd.2017.10.038","article-title":"Diabetes and pregnancy","volume":"42","author":"Feig","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.crwh.2026.e00831_bb0060","series-title":"Weight Gain in Pregnancy","author":"Rasmussen","year":"2009"},{"key":"10.1016\/j.crwh.2026.e00831_bb0065","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf146","article-title":"Cardiometabolic risk factors and adverse outcomes in pregnant women with type 2 diabetes","volume":"9","author":"Koefoed","year":"2025","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.crwh.2026.e00831_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-085710","article-title":"Gestational weight gain and risk of adverse maternal and neonatal outcomes in observational data from 1.6 million women: systematic review and meta-analysis","volume":"391","author":"Goldstein","year":"2025","journal-title":"BMJ"}],"container-title":["Case Reports in Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214911226000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214911226000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:03:17Z","timestamp":1788163397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214911226000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"alternative-id":["S2214911226000536"],"URL":"https:\/\/doi.org\/10.1016\/j.crwh.2026.e00831","relation":{},"ISSN":["2214-9112"],"issn-type":[{"value":"2214-9112","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetrical and medical outcomes following GLP-1 receptor agonist exposure in pregnancy: a case series","name":"articletitle","label":"Article Title"},{"value":"Case Reports in Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crwh.2026.e00831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00831"}}